Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial
- Magrini, Stefano Maria
- Buglione di Monale e Bastia, Michela
- Corvò, Renzo
- Pirtoli, Luigi
- Paiar, Fabiola
- Ponticelli, Pietro
- Petrucci, Alessia
- Bacigalupo, Almalina
- Crociani, Monica
- Lastrucci, Luciana
- Vecchio, Stefania
- Bonomo, Pierluigi
- Pasinetti, Nadia
- Triggiani, Luca
- Cavagnini, Roberta
- Costa, Loredana
- Tonoli, Sandro
- Maddalo, Marta
- Grisanti, Salvatore
Publication date
January 2015
DOI Publisher
American Society of Clinical Oncology (ASCO) ISSN
0732-183XAbstract
No randomized trials have been conducted to directly compare radiotherapy (RT) with concomitant cisplatin (CDDP) versus concomitant cetuximab (CTX) as first-line treatment of locally advanced squamous cell carcinoma of the head and neck. In this randomized trial, we compared these two treatment regimens in terms of compliance, toxicity, and efficacy
Add to ORKG